<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="review-article" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Ann Med</journal-id><journal-id journal-id-type="iso-abbrev">Ann Med</journal-id><journal-id journal-id-type="pmc-domain-id">3997</journal-id><journal-id journal-id-type="pmc-domain">annmed</journal-id><journal-title-group><journal-title>Annals of Medicine</journal-title></journal-title-group><issn pub-type="ppub">0785-3890</issn><issn pub-type="epub">1365-2060</issn><publisher><publisher-name>Taylor &amp; Francis</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10120558</article-id><article-id pub-id-type="pmcid-ver">PMC10120558.1</article-id><article-id pub-id-type="pmcaid">10120558</article-id><article-id pub-id-type="pmcaiid">10120558</article-id><article-id pub-id-type="pmid">37074264</article-id><article-id pub-id-type="doi">10.1080/07853890.2023.2197289</article-id><article-id pub-id-type="publisher-id">2197289</article-id><article-version-alternatives><article-version article-version-type="pmc-version">1</article-version><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" vocab-term="Version of Record" article-version-type="VoR">Version of Record</article-version></article-version-alternatives><article-categories><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Pregnancy, Childbirth &amp; Women's Health</subject></subj-group></article-categories><title-group><article-title>SARS CoV-2 infection as a risk factor of preeclampsia and pre-term birth. An interplay between viral infection, pregnancy-specific immune shift and endothelial dysfunction may lead to negative pregnancy outcomes</article-title><alt-title alt-title-type="left-running-head">A. Celewicz et al.</alt-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8877-0266</contrib-id><name name-style="western"><surname>Celewicz</surname><given-names initials="A">Aleksander</given-names></name><xref rid="AF0001" ref-type="aff">a</xref><xref rid="AN0001" ref-type="corresp"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-1849-9498</contrib-id><name name-style="western"><surname>Celewicz</surname><given-names initials="M">Marta</given-names></name><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9554-7580</contrib-id><name name-style="western"><surname>Michalczyk</surname><given-names initials="M">Micha&#322;</given-names></name><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-4696-2956</contrib-id><name name-style="western"><surname>Wo&#378;niakowska-Gondek</surname><given-names initials="P">Paula</given-names></name><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-3106-8767</contrib-id><name name-style="western"><surname>Krejczy</surname><given-names initials="K">Kamila</given-names></name><xref rid="AF0001" ref-type="aff">a</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-6773-6093</contrib-id><name name-style="western"><surname>Misiek</surname><given-names initials="M">Marcin</given-names></name><xref rid="AF0002" ref-type="aff">b</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-9294-1005</contrib-id><name name-style="western"><surname>Rzepka</surname><given-names initials="R">Rafa&#322;</given-names></name><xref rid="AF0001" ref-type="aff">a</xref></contrib><aff id="AF0001"><label>a</label><institution>Department of Gynecology and Obstetrics, Collegium Medicum, University of Zielona G&#243;ra</institution>, <postal-code>65-417</postal-code><city>Zielona G&#243;ra</city>, <country>Poland</country></aff><aff id="AF0002"><label>b</label><institution>Holy Cross Cancer Center Clinical Gynecology</institution>, <city>Kielce</city>, <country>Poland</country></aff></contrib-group><author-notes><corresp id="AN0001">CONTACT Aleksander Celewicz <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="mailto:a.celewicz@gmail.com">a.celewicz@gmail.com</email><institution>Department of Gynecology and Obstetrics, Collegium Medicum, University of Zielona G&#243;ra</institution>, <postal-code>65-417</postal-code><city>Zielona G&#243;ra</city>, <country>Poland</country></corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>19</day><month>4</month><year>2023</year></pub-date><pub-date date-type="collection" publication-format="electronic"><year>2023</year></pub-date><volume>55</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">422386</issue-id><elocation-id>2197289</elocation-id><pub-history><event event-type="pmc-release"><date><day>19</day><month>04</month><year>2023</year></date></event><event event-type="pmc-live"><date><day>22</day><month>04</month><year>2023</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-09 11:25:16.700"><day>09</day><month>03</month><year>2025</year></date></event><event event-type="received"><date><day>18</day><month>10</month><year>2021</year></date></event><event event-type="revised"><date><day>21</day><month>1</month><year>2023</year></date></event><event event-type="accepted"><date><day>26</day><month>3</month><year>2023</year></date></event><event event-type="tagger"><event-desc>KnowledgeWorks Global Ltd.</event-desc><date><day>18</day><month>4</month><year>2023</year></date></event><event event-type="build-issue-online"><event-desc>published online in a building issue</event-desc><date><day>18</day><month>4</month><year>2023</year></date></event></pub-history><permissions><copyright-statement>&#169; 2023 The Author(s). Published by Informa UK Limited, trading as Taylor &amp; Francis Group</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The terms on which this article has been published allow the posting of the Accepted Manuscript in a repository by the author(s) or with their consent.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="IANN_55_2197289.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pdf" xlink:href="IANN_55_2197289.pdf"/><abstract><title>Abstract</title><sec><title>Background</title><p>Since SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) was first identified as the cause of Coronavirus disease 19 (COVID-19) it has caused over 649,147,421 infections and over 6,730,382 deaths worldwide. SARS-CoV-2 presents higher infectivity than other coronaviridae (MERS-CoV and SARS-CoV). Pregnant patients, according to previous studies are at high risk of severe COVID-19 course and negative pregnancy outcomes (pre-term birth, low birth weight, preeclampsia, operative delivery and ICU admission with need for mechanical ventilation).</p></sec><sec><title>Methods</title><p>In this review we focus on the pathophysiology of subcellular changes in COVID-19 and try bring to light the aspects that occur in physiological pregnancy that may cause higher risk of SARS-CoV-2 infection and severe COVID-19 course.</p></sec><sec><title>Results</title><p>Knowledge of potential interplay between viral infection and physiological changes in pregnancy may point us in the direction of future prophylaxis and treatment in this special population.</p><p>
<list list-type="bullet"><title>Key Messages</title><list-item><p>SARS-CoV-2 having affinity to ACE-2 and causing it&#8217;s downregulation receptor may cause endothelial injury leading to compliment activation and formation of NETs, together with RAS dysregulation this may cause preeclampsia to develop in pregnant patients.</p></list-item><list-item><p>PTB may occur in patients as an effect of SARS-CoV-2 infection in first or second trimester as an effect of TLR4 pathway dysregulation with lower levels of IFN&#946;.</p></list-item></list>
</p></sec></abstract><kwd-group kwd-group-type="author"><title>Keywords</title><kwd>COVID-19</kwd><kwd>pregnancy</kwd><kwd>pre-term birth</kwd><kwd>preeclampsia</kwd><kwd>subcellular changes</kwd><kwd>SARS-CoV-2</kwd></kwd-group><support-group><funding-group><funding-statement>This research received no external funding.</funding-statement></funding-group></support-group><counts><fig-count count="2"/><table-count count="0"/><page-count count="10"/><word-count count="6367"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" disp-level="1" id="S0001"><title>Introduction</title><p>Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was identified as the causative agent behind Coronavirus disease 19 (COVID-19) in late 2019. Since then it has already caused over 649,147,421 infections [<xref rid="CIT0001" ref-type="bibr">1</xref>] and over 6,730,382 deaths [<xref rid="CIT0001" ref-type="bibr">1</xref>] worldwide. In 11 March 2020 WHO declared a state of pandemic. SARS-CoV-2 is an RNA virus related to severe acute respiratory syndrome coronavirus (SARS-CoV) and Middle East respiratory syndrome coronavirus (MERS-CoV) [<xref rid="CIT0002" ref-type="bibr">2</xref>]. The whole family of coronaviridae has strong affinity to angiotensin II converting enzyme (ACE2) receptor and can replicate in cells with expression of aforementioned receptor [<xref rid="CIT0003" ref-type="bibr">3</xref>,<xref rid="CIT0004" ref-type="bibr">4</xref>]. The SARS-CoV-2 pandemic with its high number of asymptomatic and low-symptomatic patients is highly infectious and has claimed a higher death toll than SARS-CoV and MERS-CoV epidemics [<xref rid="CIT0005" ref-type="bibr">5</xref>]. Pregnant women with COVID-19 are at higher risk of severe course and negative pregnancy outcomes (caesarean delivery, pre-term birth (PTB), low birth weight, preeclampsia (PE), ICU admission and need for mechanical ventilation). As well as are at higher risk of developing pregnancy specific disorders (PE, PTB and premature preterm rupture of membranes). We focus on the subcellular changes that occur in pregnant women with COVID-19 to try to elucidate how those disorders may be triggered by the infection with SARS-CoV-2.</p></sec><sec disp-level="1" id="S0002"><title>Outcomes of COVID-19 in pregnancy</title><sec disp-level="2" id="S0002-S2001"><title>Microvascular changes in COVID-19 AND PE</title><sec disp-level="3" id="S0002-S2001-S3001"><title>PE and renin-angiotensin system (RAS)</title><p>PE is a disorder specific to pregnancy, complicating 2%&#8211;8% of pregnancies worldwide and is defined by The International Society for the Study of Hypertension in Pregnancy as a combination of arterial hypertension and proteinuria (&gt;300&#8201;mg/day) present after 20&#8201;weeks of gestation, or as arterial hypertension which is accompanied by one of the following: thrombocytopenia, impaired liver function, renal insufficiency, pulmonary oedema, neurological abnormalities, foetal growth restriction (FGR) or placental insufficiency [<xref rid="CIT0006" ref-type="bibr">6&#8211;8</xref>]. A shift in the balance between Ang II/Ang-(1-7) with the former being boosted and latter presenting declining levels is also present in PE [<xref rid="CIT0009" ref-type="bibr">9</xref>,<xref rid="CIT0010" ref-type="bibr">10</xref>]. Similar effect is observed in COVID-19, when SARS-CoV-2 binds to ACE-2 and causes it&#8217;s downregulation accelerating RAS dysregulation. In effect it may start the cascade of changes that develop into late-onset PE in the III trimester [<xref rid="CIT0011" ref-type="bibr">11</xref>].</p></sec><sec disp-level="3" id="S0002-S2001-S3002"><title>Interplay between endothelial injury and compliment activation</title><p>Another key feature of PE is multiorgan endothelial cell dysfunction leading to the most severe forms such as HELLP or eclampsia [<xref rid="CIT0012" ref-type="bibr">12</xref>]. Endothelial dysfunction leading to dysregulation of coagulation is also one of the most important mechanisms in severe COVID-19 [<xref rid="CIT0011" ref-type="bibr">11</xref>]. As ACE-2 is expressed in endothelial cells it is possible that during severe COVID-19 these cells become infected by SARS-CoV-2 [<xref rid="CIT0013" ref-type="bibr">13</xref>,<xref rid="CIT0014" ref-type="bibr">14</xref>] leading to immune mediated endothelial injury [<xref rid="CIT0015" ref-type="bibr">15</xref>,<xref rid="CIT0016" ref-type="bibr">16</xref>]. Resulting endothelitis causes compliment activation and formation of C5b-9 complex in high quantities which causes further activation of the common coagulation pathway, with formation of fibrin deposits and increase in D-Dimer levels [<xref rid="CIT0017" ref-type="bibr">17</xref>,<xref rid="CIT0018" ref-type="bibr">18</xref>]. Compliment activation is followed by attraction of neutrophils to the loci of endothelial injury, proven by the observation that neutrophilia and specifically high neutrophil-to-lymphocyte ratio (NLR) is a marker of poor prognosis in COVID-19 [<xref rid="CIT0019" ref-type="bibr">19</xref>,<xref rid="CIT0020" ref-type="bibr">20</xref>].</p></sec><sec disp-level="3" id="S0002-S2001-S3003"><title>Factors contributing to higher risk of thrombotic microangiopathy (TMA)</title><p>Damage-associated molecular patterns are the triggers for recognition receptors sites (Toll-like receptors (TLR) and inflammasomes) binding to neutrophil surface through L-selectin and P-selectin glycoprotein ligand 1 [<xref rid="CIT0021" ref-type="bibr">21</xref>]. After activation they undergo degranulation and phagocytosis of the infectious factors may begin, as this process is physiological it should not lead to further cell injury [<xref rid="CIT0022" ref-type="bibr">22</xref>]. What may induce TMA is formation of neutrophil extracellular traps (NETs) [<xref rid="CIT0023" ref-type="bibr">23</xref>]. This process is composed of decondensation and expansion of chromatin and release of granules to the space surrounding neutrophils [<xref rid="CIT0024" ref-type="bibr">24</xref>]. NETs express presence of peptidylearginine deiminase (PAD4) an enzyme that may change a disintegrins and metalloproteinase with thrombospondin type 1 repeats, member 13 (ADAMTS13) structure reducing it&#8217;s potential to destroy von Willebrand factor multimers, promoting activation of platelets [<xref rid="CIT0025" ref-type="bibr">25</xref>,<xref rid="CIT0026" ref-type="bibr">26</xref>]. Usually ADAMTS13 activity is not decreased during acute phase of inflammation but majority of patients with COVID-19 were presenting lower ADAMTS13 activity, which may be explained by underlying endothelial cell injury [<xref rid="CIT0027" ref-type="bibr">27</xref>]. Thus low ADAMTS13 levels are correlated with higher risk of TMA and poor outcome in COVID-19 patients. During normal pregnancy ADAMTS13 is being produced also by the placenta and reaches higher concentration than in non-pregnant individuals [<xref rid="CIT0028" ref-type="bibr">28</xref>], with the highest concentration in the first trimester, which gradually declines in the second, third trimester and at term pregnancy [<xref rid="CIT0029" ref-type="bibr">29</xref>]. This decline is consistent with reduced placental expression of ADAMTS13 throughout the pregnancy that correlates with decreased placental perfusion [<xref rid="CIT0030" ref-type="bibr">30</xref>]. What more the decreased (serum and placental) ADAMTS13 levels were found during ischaemic conditions and in severe PE [<xref rid="CIT0030" ref-type="bibr">30</xref>,<xref rid="CIT0031" ref-type="bibr">31</xref>]. <xref rid="F0001" ref-type="fig">Figure 1</xref> depicts the processes described above.</p></sec><sec disp-level="3" id="S0002-S2001-S3004"><title>Effects of SARS-CoV-2 infection on the placenta</title><p>We suspect that COVID-19 may either mimic initiate or act synergistic with an underlying microvascular endothelial injury and endothelitis fuelling vasoconstriction and ischaemia [<xref rid="CIT0011" ref-type="bibr">11</xref>]. Together with pregnancy induced hypercoagulability COVID-19 greatly increases thromobitic risk. All the aforementioned changes may contribute to an increased risk of negative pregnancy outcomes in patients with pre-existing PE during SARS-CoV-2 infection. The next step is to consider evidence whether SARS-CoV-2 infection during first and early second trimester of pregnancy disrupts trophoblast invasion and triggers vascular changes with PE being the final outcome (<xref rid="F0001" ref-type="fig">Figure 1</xref>) [<xref rid="CIT0032" ref-type="bibr">32</xref>,<xref rid="CIT0033" ref-type="bibr">33</xref>].</p><fig position="float" id="F0001" orientation="portrait"><label>Figure 1.</label><caption><p>Effect of SARS-CoV-2 infection on risk of PE, PTB and FGR.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="color" position="float" orientation="portrait" xlink:href="IANN_A_2197289_F0001_C.jpg"/></fig><list list-type="order"><list-item><p>Due to SARS-Cov-2 affinity to ACE-2 receptor, it&#8217;s higher expression in pregnancy may cause higher risk of infection during pregnancy</p></list-item><list-item><p>ACE-2 is expressed in endothelial cells and when they become infected by SARS-CoV-2 it may lead to immune mediated endothelial injury</p></list-item><list-item><p>Endothelitis causes compliment activation and formation of C5b-9 complex causing activation of the common coagulation pathway. Neutrophils are attracted to the loci of endothelial injury, they may undergo decondensation and expansion of chromatin and release of granules to the space surrounding neutrophils &#8211; process that is known as NET formation.</p></list-item><list-item><p>NETs express presence of PAD4 an enzyme that may change ADAMTS13 structure reducing it&#8217;s potential to destroy von Willebrand factor multimers promoting activation of platelets.</p></list-item><list-item><p>Points (3) and (4) sum up to result in higher TMA risk and induction of ischaemic changes, that is, in the placenta</p></list-item><list-item><p>SARS-CoV-2 causes ACE-2 downregulation and may accelerate RAS dysregulation summing it up with a pre-existing potential to develop PE or initiating the cascade of changes that may develop into late-onset PE</p></list-item><list-item><p>Following RAS dysregulation a shift in the balance between Ang II/Ang-(1-7) occurs adding the vasoconstrictive effect, increasing blood pressure, further damaging endothelial cells and in effect mimicking or worsening vascular dysfunction in PE</p></list-item><list-item><p>All those aforementioned changes may be the agents behind PE, FGR or PTB</p></list-item></list><p>Placental expression of SARS-CoV-2 cell entry proteins (ACE2 and TMPRSS2) is highest in the first trimester, with declining levels throughout the progress of the pregnancy. What is notable those levels are unchanged in pregnancies complicated by PTB (iatrogenic or spontaneous) or in those where PE occurred [<xref rid="CIT0034" ref-type="bibr">34</xref>]. The implication seems clear: placenta during the first trimester is more vulnerable to SARS-CoV-2 infection, this is supported by the observations of negative outcomes from SARS and MERS epidemics [<xref rid="CIT0035" ref-type="bibr">35</xref>], as well as proven placental presence of SARS-CoV-2 regardless whether the infection occurred in second or third trimester [<xref rid="CIT0036" ref-type="bibr">36</xref>,<xref rid="CIT0037" ref-type="bibr">37</xref>]. This may be the key factor in developing inflammation and oxidative stress in the placental tissue, which is associated with PE [<xref rid="CIT0038" ref-type="bibr">38</xref>].</p><p>In an <italic toggle="yes">in-silico</italic> study proteins that interact with SARS-CoV-2 were found in placental tissue (namely TLE3 and LOX). Levels of both of them were increased in early as well as at term pregnancies [<xref rid="CIT0039" ref-type="bibr">39</xref>]. TLE3 and LOX play a role in placentation and arterial remodelling, and their downregulation (in transgenic TLE3-deficient mice) has been associated with in utero demise, as well as abnormal placental development, major changes in maternal vasculature and spiral artery remodelling [<xref rid="CIT0040" ref-type="bibr">40</xref>]. This finding is concordant with histological findings in placental tissue collected from pregnant COVID-19 patients where decidual arteriopathy including atherosis, fibrinoid necrosis and mural hypertrophy of membrane arterioles was reported [<xref rid="CIT0041" ref-type="bibr">41</xref>]. Features mentioned above are parts of maternal vascular malperfusion (MVM), which is found in pregnancies complicated by FGR, preterm birth and oligohydramnios [<xref rid="CIT0042" ref-type="bibr">42</xref>,<xref rid="CIT0043" ref-type="bibr">43</xref>]. Prior to COVID-19 pandemic MVM was most commonly diagnosed in cases of PE [<xref rid="CIT0044" ref-type="bibr">44</xref>,<xref rid="CIT0045" ref-type="bibr">45</xref>].</p></sec><sec disp-level="3" id="S0002-S2001-S3005"><title>Controversies concerning PE incidence in COVID-19 patients</title><p>Even though the pathological pathways leading to PE in COVID-19 patients show logical continuity there are discrepancies between studies reporting it&#8217;s incidence. In a case-control study performed by Guido et&#160;al. [<xref rid="CIT0046" ref-type="bibr">46</xref>] on a group of 203 COVID-19 (+) and 197 COVID-19 (&#8211;) pregnant women has shown that PE was diagnosed in 10.3% of COVID-19 (+) and 13.1% COVID-19 (&#8211;) patients. Although the group reported no statistical significance to these findings. What weighs importance is a highlight to this study pointing to other comorbidities such as chronic hypertension (33.4%) and obesity (60.0%) in women with SARS-CoV-2 infection were associated with PE. In PE negative group it was respectively 5.5% and 32.8% with results being statistically significant. Another study by Tran et&#160;al. [<xref rid="CIT0047" ref-type="bibr">47</xref>] also reported no significance in prevalence of PE in pregnant patients. The authors report 3.2% incidence of PE out of 93 SARS-CoV-2 infected women and in the group of 186 SARS-CoV-2 negative women 2.2% were diagnosed with PE. Marchand et&#160;al. [<xref rid="CIT0048" ref-type="bibr">48</xref>] performed a systemic review of 111 studies comprised of 42754 pregnant women with SARS-CoV-2 infection. They have found a 7% rate of PE and an OR 1.6 in infected women. However when considering the quality of the studies and a heterogenous testing regime and patient group they concluded that these findings where not significant.</p><p>In a study by a group from Mexico [<xref rid="CIT0049" ref-type="bibr">49</xref>] an increase in PE rate in third trimester patients with SARS-CoV-2 infection (18%) when compared to negative patients (9%) with OR 2.2. Further support is found in the INTERCOVID cohort study performed by Villar et&#160;al. [<xref rid="CIT0050" ref-type="bibr">50</xref>]. The authors report higher incidence of pregnancy induced hypertension (RR 1.46) and PE/eclampsia/HELLP (RR 1.76) in COVID-19 patients when compared to COVID-19 negative women. Difference in findings were addressed in a systemic review by Tossetta et&#160;al. [<xref rid="CIT0051" ref-type="bibr">51</xref>]. The group pointed to the fact that COVID-19 may cause a PE-like syndrome thus we may hypothesize this may a be a factor that caused higher incidence rates in some studies. Moreover most studies do not discriminate different severity grades of COVID-19.</p><p>A possible explanation to these discrepancies and an insight to the effects and importance of ACE2 regulation in the placental response against SARS-CoV-2 was delivered by Taglauer et&#160;al. [<xref rid="CIT0052" ref-type="bibr">52</xref>] comparing ACE2 placental expression in chorionic villi and maternal serum ACE2 in COVID-19 patients. Transmembrane ACE2 is comprised of an ectodomain to which SARS-CoV-2 may bind [<xref rid="CIT0053" ref-type="bibr">53</xref>,<xref rid="CIT0054" ref-type="bibr">54</xref>]. Although in response to viral or bacterial infection this ectodomain may undergo shedding forming a soluble form of ACE2 still enzymatically active and able to bind viral particles [<xref rid="CIT0052" ref-type="bibr">52</xref>]. As such this soluble ACE2 may act as a decoy receptor to inert SARS-CoV-2 and is being trialled as a therapy agent [<xref rid="CIT0054" ref-type="bibr">54</xref>]. Still alternative routes of SARS-CoV-2 cellular entry may be enabled by this soluble ACE2 [<xref rid="CIT0052" ref-type="bibr">52</xref>]. The main finding of the aforementioned study is the lower placental expression of ACE2 in third trimester SARS-CoV-2 infection in comparison of second trimester infection and healthy patients. The decreased ACE2 expression was lower in the same samples were serum ACE2 was increased. What was also proven was the fact that ACE2 was not expressed in the endothelium of foetal blood vessels of the placenta. This may provide an answer for the different results found in the studies and support the hypothesis that PE diagnosed in COVID-19 third trimester patients is in fact a PE-like syndrome. As well as supports the findings of low (0.5%&#8722;2.5%) vertical transmission rates of SARS-CoV-2 to the foetus [<xref rid="CIT0037" ref-type="bibr">37</xref>].</p></sec></sec><sec disp-level="2" id="S0002-S2002"><title>COVID-19 immune response and risk of preterm birth</title><sec disp-level="3" id="S0002-S2002-S3001"><title>Immune shift in pregnancy may have an effect on the course of viral infection</title><p>Severe COVID-19 pathogenesis is caused by dysregulation of inflammatory cascade; however, this process may become attenuated in pregnant patients thus ensuring more bening or even asymptomatic course of the disease. The response of the pregnant women to SARS-CoV-2 infection may be partially dependant on the age of the gestation at which it occurs. During the first trimester a pro-inflammatory state that benefits implantation of the embryo is observed, followed by an anti-inflammatory suppression, promoting foetal growth, in second trimester, to finally reach the third trimester with yet another pro-inflammatory shift promoting cervical maturation and labour onset [<xref rid="CIT0055" ref-type="bibr">55</xref>]. It is important to note that throughout the duration of pregnancy the immune shift is a very subtle process not a simple immunosuppression, as it was proven that deletion of immune cells in the implantation site leads to early pregnancy loss [<xref rid="CIT0055" ref-type="bibr">55</xref>].</p></sec><sec disp-level="3" id="S0002-S2002-S3002"><title>COVID-19 effect on pro-inflammatory factors</title><p>There is broad evidence supporting the fact that viral infection in the gravid mother can have a negative effect on the pregnancy, cause birth defects or pregnancy loss [<xref rid="CIT0056" ref-type="bibr">56</xref>]. MERS-CoV and SARS-CoV epidemics proved that spontaneous abortion, premature birth, and FGR may be an effect of the viral infection. But it must be stated that vertical transmission of SARS-CoV-2 infection is extremely rare [<xref rid="CIT0035" ref-type="bibr">35</xref>,<xref rid="CIT0057" ref-type="bibr">57</xref>]. The events that trigger ARDS in COVID-19 are elevated serum levels of proinflammatory cytokines such as IL-1&#946;, IL-2, IL-6, IL-7, IL-17 and tumour necrosis factor &#945; (TNF-&#945;), interferon gamma (INF-&#947;) [<xref rid="CIT0058" ref-type="bibr">58</xref>,<xref rid="CIT0059" ref-type="bibr">59</xref>]. The rise of those cytokine concentration is due to interstitial pneumonia caused by SARS-CoV-2 and is particularly high in severe course of COVID-19 [<xref rid="CIT0060" ref-type="bibr">60</xref>]. The resulting cytokine storm may be the agent behind macrophage activation syndrome (MAS), and the hyperresponsive immune system is initially confined in the lung parenchyma but extends gradually onto lymphoid tissue, and through pulmonary blood vessels onto other organs [<xref rid="CIT0060" ref-type="bibr">60</xref>]. Evidence for inflammation occurring in the placental tissue in SARS-CoV-2 infected patients has been delivered by Juttukonda et&#160;al. [<xref rid="CIT0037" ref-type="bibr">37</xref>]. It has been observed that levels of macrophage and NK cells were higher in third trimester infection in comparison to second trimester infection and negative control group. In comparison lymphocyte T levels were higher only in third trimester infection. Cytokine expression in the placenta is also correlated with increased macrophage levels, as third trimester cytokine levels were found to be higher and second trimester infection was correlated with downregulation of these cytokine levels over time. This may point to an adaptive immune response in third trimester SARS-CoV-2 infection, but also that earlier infections during pregnancy show signs of resolving immune response at term [<xref rid="CIT0037" ref-type="bibr">37</xref>]. Further evidence for resolving infection was found observing first trimester SARS-CoV-2 infection and vaccinated population in comparison to SARS-CoV-2 negative group. Levels of decidual macrophages, NK cells, T cells and cytokines were matching in all these subgroups (<xref rid="F0002" ref-type="fig">Figure 2</xref>) [<xref rid="CIT0061" ref-type="bibr">61</xref>].</p><fig position="float" id="F0002" orientation="portrait"><label>Figure 2.</label><caption><p>The double-hit hypothesis.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" content-type="color" position="float" orientation="portrait" xlink:href="IANN_A_2197289_F0002_C.jpg"/></fig><list list-type="order"><list-item><p><bold>In absence of viral infection maternal microbiota is responsible for baseline type I IFN production.</bold> TLR4 on the surface of trophoblast cell respond to LPS and as an effect of TLR4 and LPS connection produce type I IFN and NF-&#954;B inflammatory pathway is inhibited. Thus production of IFN&#946; begins&#8212;an agent able to modulate inflammatory process. This causes apoptosis in activated T cells and increase in production of PDL1 and IDO all of which have a protective effect for the placental tissue. This promotes immune tolerance for the developing foetus.</p></list-item><list-item><p><bold>In cells</bold>
<bold>infected</bold>
<bold>with SARS-CoV-2 the following scenario may occur.</bold> Presence of a viral infection modification of TLR4 pathways occurs which promotes a pro-inflammatory response. Production of IFN&#946; is attenuated and decreased IFN&#946; levels may cause disability of immune cells to control and respond to commensal microbiota. This causes further inflammatory cascade to take place and increases the risk of pPROM and PTB.</p></list-item></list></sec><sec disp-level="3" id="S0002-S2002-S3003"><title>COVID-19 and the &#8216;double-hit hypothesis&#8217;</title><p>One of the potential pathways of inducing PTB in COVID-19 patients is a &#8216;double-hit hypothesis&#8217; of bacterial and viral co-infection [<xref rid="CIT0055" ref-type="bibr">55</xref>]. The basis of the hypothesis is presence of maternal microbiota in the materno-foetal interface responsible for a baseline IFN&#945; and IFN&#946; (type I interferons) production which is modulating maternal immune system and has a potential to induce immune tolerance for the developing foetus [<xref rid="CIT0062" ref-type="bibr">62</xref>]. It is proven that trophoblast cells express TLRs and NLRs in response to bacterial lipopolysaccharides (LPS), as an effect of TLR4 and LPS connection trophoblast cells start the production of type I IFN occurs rather than nuclear factor (NF-&#954;B) inflammatory complex [<xref rid="CIT0055" ref-type="bibr">55</xref>,<xref rid="CIT0063" ref-type="bibr">63</xref>]. IFN&#946; has been proven to be expressed in mammalian placental tissue, it possess the ability to: induce an antimicrobial state, modulate innate immune responses, activate adaptive immune system [<xref rid="CIT0064" ref-type="bibr">64&#8211;66</xref>]. The point of effect of IFN&#946; is the TLR signalling pathway, through which it is able to modulate inflammatory process [<xref rid="CIT0067" ref-type="bibr">67</xref>,<xref rid="CIT0068" ref-type="bibr">68</xref>]. IFN&#945; and IFN&#946; are capable of inducing apoptosis in activated T cells and in the same time increase IL-10, programmed cell death 1 ligand 1 (PDL1) and indoleamine 2,3 dioxygenase (IDO) all of which have a protective effect for the placental tissue [<xref rid="CIT0069" ref-type="bibr">69&#8211;71</xref>]. The &#8216;double-hit hypothesis&#8217; explains how a viral infection can attenuate IFN&#946; expression stopping the placental antiviral activity (<xref rid="F0002" ref-type="fig">Figure 2</xref>) [<xref rid="CIT0055" ref-type="bibr">55</xref>]. Presence of a viral infection modifies TLR4 pathways present as a reaction to pregnant women&#8217;s microbiota, and promotes a pro-inflammatory response [<xref rid="CIT0062" ref-type="bibr">62</xref>]. As the conclusion may be elucidated that IFN&#946; promotes immune cell receptivity and tolerance for the foetal antigens at the materno-foetal border, viral infection may result in decreased IFN&#946; levels causing disability of immune cells to control and respond to commensal microbiota [<xref rid="CIT0055" ref-type="bibr">55</xref>,<xref rid="CIT0072" ref-type="bibr">72</xref>]. It was reported by Cardenas et&#160;al. in an animal study, that induction of viral infection and stimulation with low doses of LPS resulted in reduction of IFN&#946; production, cytokine storm (with high levels of C-X-C motif chemokine ligand 10 (CXCL10), granulocyte-colony stimulating factor (G-CSF), TNF, IL 8&#8212;all associated with labour induction) and finally preterm birth [<xref rid="CIT0073" ref-type="bibr">73&#8211;75</xref>]. These cytokine shifts were not observed in cases were LPS was administered without viral infection, nor when viral infection was induced but LPS was not administered [<xref rid="CIT0076" ref-type="bibr">76</xref>]. This leads to the conclusion that a viral infection such as SARS-CoV-2 may infect trophoblast cells and change their response from immune tolerance to pro-inflammatory promoting preterm birth.</p></sec><sec disp-level="3" id="S0002-S2002-S3004"><title>Effect of pregnancy associated immune shift on the course of COVID-19</title><p>When considering the response of the pregnant women with COVID-19 it is essential to take into account the Th1/Th2 immune shift. The physiological attenuation of the proinflammatory Th1 related cytokines, lasting until third trimester [<xref rid="CIT0055" ref-type="bibr">55</xref>], can be a protective factor form extensive pulmonary damage and ARDS, as it was reported that IL-1&#946;, IL-6, TNF-&#945; are a good marker of cytokine response (and cytokine storm), with their lower serum levels associated with higher survival rates [<xref rid="CIT0077" ref-type="bibr">77</xref>]. On the other hand Th2 related cytokines (IL-4, IL-10, IL-13 and transforming growth factor beta (TGF-&#946;)) have an anti-inflammatory potential. In pregnant COVID-19 patients the shift from Th1 to Th2 related response [<xref rid="CIT0078" ref-type="bibr">78</xref>] has the ability to decelerate a dysregulated immune response not allowing the cytokine storm to occur [<xref rid="CIT0060" ref-type="bibr">60</xref>]. Upon third trimester the Th1 response becomes augmented and the response on SARS-CoV-2 infection has the potential to become dysregulated, on the same level as in a non-pregnant patients but with all the drawbacks of the changes in the respiratory and cardiovascular system that occur in pregnant women. This may have an effect on the rate of PTB, as it was reported that PTB and caesarean delivery (CD) is more common in SARS and MERS infection as well as in COVID-19 [<xref rid="CIT0032" ref-type="bibr">32</xref>,<xref rid="CIT0050" ref-type="bibr">50</xref>,<xref rid="CIT0079" ref-type="bibr">79</xref>], according to Adhikari et&#160;al. [<xref rid="CIT0080" ref-type="bibr">80</xref>] the rate of PTB is the same in SARS-CoV-2 positive as in SARS-CoV-2 negative group (RR 1.02). On the other hand Allotey et&#160;al. [<xref rid="CIT0081" ref-type="bibr">81</xref>] report in their &#8216;living review and meta-analysis&#8217; higher rates of PTB In SARS-CoV-2 positive women (OR 1.47). What question is still present is the cause of PTB as most of COVID-19 patients are diagnosed in third trimester, and in those patients the decision of ending the pregnancy <italic toggle="yes">via</italic> CD may be dictated by deteriorating condition of the mother and ongoing pneumonia. In aforementioned studies [<xref rid="CIT0037" ref-type="bibr">37</xref>,<xref rid="CIT0052" ref-type="bibr">52</xref>,<xref rid="CIT0061" ref-type="bibr">61</xref>] presenting evidence of immune response in the placental tissue of patients with third trimester infection and resolving inflammation at term when infection occurred in second trimester a controversy remains. The studied group only had 1 patient that required hospital treatment for COVID-19 and all of the samples that were collected for the study were taken at term delivery. This points out to a pre-selected group of women that did not develop PTB nor pRPOM as well as there was no need for obstetric intervention and earlier delivery. From the previous chapter we reviewed MVM and changes associated with endothelitis in the placenta. These changes may have the potential to induce spontaneous PTB with pPROM (premature preterm rupture of membranes) being the clinical manifestation [<xref rid="CIT0034" ref-type="bibr">34</xref>]. The data published so far shows scarce percentage of pregnant patients that were diagnosed in first and only slightly higher number of patients in second trimester. We assume that most of these patients were suffering from symptomatic COVID-19 with moderate or severe course. We lack data concerning asymptomatic COVID-19 patients in the first and second trimester of pregnancy, and the outcomes of pregnancy in this population. Whether the rates of PTB or PE in this group is higher remains to be proven in future studies.</p></sec></sec></sec><sec disp-level="1" id="S0003"><title>Conclusions and further study directions</title><sec disp-level="2" id="S0003-S2001"><title>Our conclusions from this review are as follows</title><p>
<list list-type="bullet"><list-item><p>PTB may not be iatrogenic due to maternal complications in the third trimester (associated with ARDS in the mother), but the cascade that will eventually trigger labour may be initiated in patients that suffered SARS-CoV-2 infection in first or second trimester (whether asymptomatic or symptomatic).</p></list-item><list-item><p>PE may be a complication occurring in patients that had undergone COVID-19. Changes that occur in the decidua and early placenta during SARS-CoV-2 infection in the first and second trimester, may carry the risk of developing PE, HELLP, hypertension or FGR in the third trimester. This still needs to be differentiated from PE-like syndrome</p></list-item><list-item><p>The experiences we earn from COVID-19 in pregnant patients may be in future extrapolated onto other viral epidemics. A fact that might help decrease number of severe cases or complications that medical personnel may encounter in severe viral infection in pregnant population.</p></list-item></list>
</p></sec></sec></body><back><sec disp-level="1" id="S0004"><title>Author contributions</title><p>Aleksander Celewicz&#8212;conception and design, drafting the article, data collection; Marta Celewicz&#8212;drafting the article, data collection, analysis and interpretation; Micha&#322; Michalczyk&#8212;data collection and analysis; Paula Wo&#378;niakowska-Gondek&#8212;data collection; Kamila Krejczy&#8212;data collection; Marcin Misiek&#8212;data analysis and interpretation, critical revision of the article, final approval of the article; Rafa&#322; Rzepka&#8212;conception and design of the article, final approval of the article</p></sec><sec sec-type="COI-statement" disp-level="1" id="S0005"><title>Disclosure statement</title><p>No potential conflict of interest was reported by the author(s).</p></sec><sec sec-type="data-availability" disp-level="1" id="S0006"><title>Data availability statement</title><p>Data sharing is not applicable to this article as no new data were created or analysed in this study.</p></sec><ref-list><title>References</title><ref id="CIT0001"><label>1</label><mixed-citation publication-type="webpage"><person-group person-group-type="author"><collab>Covid-19 Coronavirus Pandemic.</collab></person-group><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1" ext-link-type="uri">https://www.worldometers.info/coronavirus/?utm_campaign=homeAdvegas1</ext-link></mixed-citation></ref><ref id="CIT0002"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Machhi</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Herskovitz</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Senan</surname><given-names>AM</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>The natural history, pathobiology, and clinical manifestations of SARS-CoV-2 infections</article-title>. <source>J Neuroimmune Pharmacol</source>. <year>2020</year>;<volume>15</volume>(<issue>3</issue>):<fpage>1</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="pmid">32696264</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s11481-020-09944-5</pub-id><pub-id pub-id-type="pmcid">PMC7373339</pub-id></mixed-citation></ref><ref id="CIT0003"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Malinowski</surname><given-names>AK</given-names></string-name>, <string-name name-style="western"><surname>Noureldin</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Othman</surname><given-names>M.</given-names></string-name></person-group><article-title>COVID-19 susceptibility in pregnancy: immune/inflammatory considerations, the role of placental ACE-2 and research considerations</article-title>. <source>Reprod Biol</source>. <year>2020</year>;<volume>25</volume>:<fpage>19</fpage>&#8211;<lpage>21</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.repbio.2020.10.005</pub-id><pub-id pub-id-type="pmcid">PMC7832785</pub-id><pub-id pub-id-type="pmid">33183974</pub-id></mixed-citation></ref><ref id="CIT0004"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Moghadam</surname><given-names>SO.</given-names></string-name></person-group><article-title>A review on currently available potential therapeutic options for covid-19</article-title>. <source>Int J Gen Med</source>. <year>2020</year>;<volume>13</volume>:<fpage>443</fpage>&#8211;<lpage>467</lpage>.<pub-id pub-id-type="pmid">32801840</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJGM.S263666</pub-id><pub-id pub-id-type="pmcid">PMC7387864</pub-id></mixed-citation></ref><ref id="CIT0005"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Rasmussen</surname><given-names>SA</given-names></string-name>, <string-name name-style="western"><surname>Smulian</surname><given-names>JC</given-names></string-name>, <string-name name-style="western"><surname>Lednicky</surname><given-names>JA</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Coronavirus disease 2019 (COVID-19) and pregnancy: what obstetricians need to know</article-title>. <source>Am J Obstet Gynecol</source>. <year>2020</year>;<volume>222</volume>(<issue>5</issue>):<fpage>415</fpage>&#8211;<lpage>426</lpage>.<pub-id pub-id-type="pmid">32105680</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2020.02.017</pub-id><pub-id pub-id-type="pmcid">PMC7093856</pub-id></mixed-citation></ref><ref id="CIT0006"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Michalczyk</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Celewicz</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Celewicz</surname><given-names>M</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>The role of inflammation in the pathogenesis of preeclampsia</article-title>. <source>Mediators Inflamm</source>. <year>2020</year>;<volume>2020</volume>:<fpage>3864941</fpage>.<pub-id pub-id-type="pmid">33082708</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2020/3864941</pub-id><pub-id pub-id-type="pmcid">PMC7556088</pub-id></mixed-citation></ref><ref id="CIT0007"><label>7</label><mixed-citation publication-type="journal"><article-title>Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222</article-title>. <source>Obstet Gynecol</source>. <year>2020</year>;<volume>135</volume>(<issue>6</issue>):<fpage>e237</fpage>&#8211;<lpage>e260</lpage>.<pub-id pub-id-type="pmid">32443079</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/AOG.0000000000003891</pub-id></mixed-citation></ref><ref id="CIT0008"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mol</surname><given-names>BWJ</given-names></string-name>, <string-name name-style="western"><surname>Roberts</surname><given-names>CT</given-names></string-name>, <string-name name-style="western"><surname>Thangaratinam</surname><given-names>S</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Pre-eclampsia</article-title>. <source>Lancet</source>. <year>2016</year>;<volume>387</volume>(<issue>10022</issue>):<fpage>999</fpage>&#8211;<lpage>1011</lpage>.<pub-id pub-id-type="pmid">26342729</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(15)00070-7</pub-id></mixed-citation></ref><ref id="CIT0009"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Merrill</surname><given-names>DC</given-names></string-name>, <string-name name-style="western"><surname>Karoly</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Chen</surname><given-names>K</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Angiotensin-(1-7) in normal and preeclamptic pregnancy</article-title>. <source>Endocrine</source>. <year>2002</year>;<volume>18</volume>(<issue>3</issue>):<fpage>239</fpage>&#8211;<lpage>245</lpage>.<pub-id pub-id-type="pmid">12450315</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1385/ENDO:18:3:239</pub-id></mixed-citation></ref><ref id="CIT0010"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lumbers</surname><given-names>ER</given-names></string-name>, <string-name name-style="western"><surname>Delforce</surname><given-names>SJ</given-names></string-name>, <string-name name-style="western"><surname>Arthurs</surname><given-names>AL</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Causes and consequences of the dysregulated maternal Renin-Angiotensin system in preeclampsia</article-title>. <source>Front Endocrinol (Lausanne)</source>. <year>2019</year>;<volume>10</volume>:<fpage>563</fpage>.<pub-id pub-id-type="pmid">31551925</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fendo.2019.00563</pub-id><pub-id pub-id-type="pmcid">PMC6746881</pub-id></mixed-citation></ref><ref id="CIT0011"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Narang</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Enninga</surname><given-names>EAL</given-names></string-name>, <string-name name-style="western"><surname>Gunaratne</surname><given-names>MDSK</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>SARS-CoV-2 infection and COVID-19 During pregnancy: a multidisciplinary review</article-title>. <source>Mayo Clin Proc</source>. <year>2020</year>;<volume>95</volume>(<issue>8</issue>):<fpage>1750</fpage>&#8211;<lpage>1765</lpage>.<pub-id pub-id-type="pmid">32753148</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mayocp.2020.05.011</pub-id><pub-id pub-id-type="pmcid">PMC7260486</pub-id></mixed-citation></ref><ref id="CIT0012"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>la Marca</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Brewer</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Wallace</surname><given-names>K.</given-names></string-name></person-group><article-title>IL-6-induced pathophysiology during pre-eclampsia: potential therapeutic role for magnesium sulfate?</article-title><source>Int J Interferon Cytokine Mediat Res</source>. <year>2011</year>;<volume>2011</volume>(<issue>3</issue>):<fpage>59</fpage>&#8211;<lpage>64</lpage>.<pub-id pub-id-type="pmid">22140321</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/IJICMR.S16320</pub-id><pub-id pub-id-type="pmcid">PMC3227031</pub-id></mixed-citation></ref><ref id="CIT0013"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Klok</surname><given-names>FA</given-names></string-name>, <string-name name-style="western"><surname>Kruip</surname><given-names>MJHA</given-names></string-name>, <string-name name-style="western"><surname>van der Meer</surname><given-names>NJM</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Incidence of thrombotic complications in critically ill ICU patients with COVID-19</article-title>. <source>Thromb Res</source>. <year>2020</year>;<volume>191</volume>:<fpage>145</fpage>&#8211;<lpage>147</lpage>.<pub-id pub-id-type="pmid">32291094</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.thromres.2020.04.013</pub-id><pub-id pub-id-type="pmcid">PMC7146714</pub-id></mixed-citation></ref><ref id="CIT0014"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ferrario</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Trask</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Jessup</surname><given-names>JA.</given-names></string-name></person-group><article-title>Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function</article-title>. <source>Am J Physiol-Hear Circ Physiol</source>. <year>2005</year>;<volume>289</volume>(<issue>6</issue>):<fpage>58</fpage>&#8211;<lpage>56</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1152/ajpheart.00618.2005</pub-id><pub-id pub-id-type="pmcid">PMC7203566</pub-id><pub-id pub-id-type="pmid">16055515</pub-id></mixed-citation></ref><ref id="CIT0015"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tang</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>X</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia</article-title>. <source>J Thromb Haemost</source>. <year>2020</year>;<volume>18</volume>(<issue>4</issue>):<fpage>844</fpage>&#8211;<lpage>847</lpage>.<pub-id pub-id-type="pmid">32073213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/jth.14768</pub-id><pub-id pub-id-type="pmcid">PMC7166509</pub-id></mixed-citation></ref><ref id="CIT0016"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Varga</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Flammer</surname><given-names>AJ</given-names></string-name>, <string-name name-style="western"><surname>Steiger</surname><given-names>P</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Endothelial cell infection and endotheliitis in COVID-19</article-title>. <source>Lancet</source>. <year>2020</year>;<volume>395</volume>(<issue>10234</issue>):<fpage>1417</fpage>&#8211;<lpage>1418</lpage>.<pub-id pub-id-type="pmid">32325026</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)30937-5</pub-id><pub-id pub-id-type="pmcid">PMC7172722</pub-id></mixed-citation></ref><ref id="CIT0017"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Legendre</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>Licht</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Muus</surname><given-names>P</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Terminal complement inhibitor eculizumab in atypical hemolytic&#8211;uremic syndrome</article-title>. <source>N Engl J Med</source>. <year>2013</year>;<volume>368</volume>(<issue>23</issue>):<fpage>2169</fpage>&#8211;<lpage>2181</lpage>.<pub-id pub-id-type="pmid">23738544</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1056/NEJMoa1208981</pub-id></mixed-citation></ref><ref id="CIT0018"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Chaturvedi</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Braunstein</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Yuan</surname><given-names>X</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Complement activity and complement regulatory gene mutations are associated with thrombosis in APS and CAPS</article-title>. <source>Blood</source>. <year>2020</year>;<volume>135</volume>(<issue>4</issue>):<fpage>239</fpage>&#8211;<lpage>251</lpage>.<pub-id pub-id-type="pmid">31812994</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood.2019003863</pub-id><pub-id pub-id-type="pmcid">PMC6978159</pub-id></mixed-citation></ref><ref id="CIT0019"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nithya</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Lamech</surname><given-names>TM</given-names></string-name>, <string-name name-style="western"><surname>Arumugam</surname><given-names>V</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>A clinical study on the changing dynamics of disease severity, management strategies and outcomes of COVID-19 in patients requiring haemodialysis</article-title>. <source>J Nephrol</source>. <year>2021</year>;<volume>29</volume>(<issue>4</issue>):<fpage>999</fpage>&#8211;<lpage>1006</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40620-021-01072-4</pub-id><pub-id pub-id-type="pmcid">PMC8164070</pub-id><pub-id pub-id-type="pmid">34050905</pub-id></mixed-citation></ref><ref id="CIT0020"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Pujani</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Raychaudhuri</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Verma</surname><given-names>N</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Association of hematologic biomarkers and their combinations with disease severity and mortality in COVID-19- an indian perspective</article-title>. <source>Am J Blood Res</source>. <year>2021</year>;<volume>11</volume>(<issue>2</issue>):<fpage>180</fpage>&#8211;<lpage>190</lpage>.<pub-id pub-id-type="pmid">34079633</pub-id><pub-id pub-id-type="pmcid">PMC8165721</pub-id></mixed-citation></ref><ref id="CIT0021"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Makatsariya</surname><given-names>AD</given-names></string-name>, <string-name name-style="western"><surname>Slukhanchuk</surname><given-names>EV</given-names></string-name>, <string-name name-style="western"><surname>Bitsadze</surname><given-names>VO</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Thrombotic microangiopathy, DIC-syndrome and COVID-19: link with pregnancy prothrombotic state</article-title>. <source>J Matern Neonatal Med</source>. <year>2020</year>;<volume>0</volume>(<issue>0</issue>):<fpage>1</fpage>&#8211;<lpage>9</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14767058.2020.1786811</pub-id><pub-id pub-id-type="pmid">32627622</pub-id></mixed-citation></ref><ref id="CIT0022"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Nicol&#225;s-&#193;vila</surname><given-names>J&#193;</given-names></string-name>, <string-name name-style="western"><surname>Adrover</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Hidalgo</surname><given-names>A.</given-names></string-name></person-group><article-title>Neutrophils in homeostasis, immunity, and cancer</article-title>. <source>Immunity</source>. <year>2017</year>;<volume>46</volume>(<issue>1</issue>):<fpage>15</fpage>&#8211;<lpage>28</lpage>.<pub-id pub-id-type="pmid">28099862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2016.12.012</pub-id></mixed-citation></ref><ref id="CIT0023"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zuo</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Kanthi</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Knight</surname><given-names>JS</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>The interplay between neutrophils, complement, and microthrombi in COVID-19</article-title>. <source>Best Pract Res Clin Rheumatol</source>. <year>2021</year>;<volume>35</volume>(<issue>1</issue>):<fpage>101661</fpage>.<pub-id pub-id-type="pmid">33526325</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.berh.2021.101661</pub-id><pub-id pub-id-type="pmcid">PMC7831864</pub-id></mixed-citation></ref><ref id="CIT0024"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Duffy</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Perrin</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Abadie</surname><given-names>V</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Neutrophils transport antigen from the dermis to the bone marrow, initiating a source of memory CD8+ T cells</article-title>. <source>Immunity</source>. <year>2012</year>;<volume>37</volume>(<issue>5</issue>):<fpage>917</fpage>&#8211;<lpage>929</lpage>.<pub-id pub-id-type="pmid">23142782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.immuni.2012.07.015</pub-id></mixed-citation></ref><ref id="CIT0025"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Morrell</surname><given-names>CN</given-names></string-name>, <string-name name-style="western"><surname>Hilt</surname><given-names>ZT</given-names></string-name>, <string-name name-style="western"><surname>Pariser</surname><given-names>DN</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>PAD4 and von willebrand factor link inflammation and thrombosis</article-title>. <source>Circ Res</source>. <year>2019</year>;<volume>125</volume>(<issue>5</issue>):<fpage>520</fpage>&#8211;<lpage>522</lpage>.<pub-id pub-id-type="pmid">31415230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/CIRCRESAHA.119.315601</pub-id><pub-id pub-id-type="pmcid">PMC10198561</pub-id></mixed-citation></ref><ref id="CIT0026"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Leffler</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Proh&#225;szka</surname><given-names>Z</given-names></string-name>, <string-name name-style="western"><surname>Mikes</surname><given-names>B</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Decreased neutrophil extracellular trap degradation in Shiga toxin-associated haemolytic uraemic syndrome</article-title>. <source>J Innate Immun</source>. <year>2017</year>;<volume>9</volume>(<issue>1</issue>):<fpage>12</fpage>&#8211;<lpage>21</lpage>.<pub-id pub-id-type="pmid">27784011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1159/000450609</pub-id><pub-id pub-id-type="pmcid">PMC6738868</pub-id></mixed-citation></ref><ref id="CIT0027"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sweeney</surname><given-names>JM</given-names></string-name>, <string-name name-style="western"><surname>Barouqa</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Krause</surname><given-names>GJ</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Low ADAMTS13 activity correlates with increased mortality in COVID-19 patients</article-title>. <source>TH Open</source>. <year>2021</year>;<volume>5</volume>(<issue>1</issue>):<fpage>e89</fpage>&#8211;<lpage>e103</lpage>.<pub-id pub-id-type="pmid">33709050</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0041-1723784</pub-id><pub-id pub-id-type="pmcid">PMC7943318</pub-id></mixed-citation></ref><ref id="CIT0028"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Plaimauer</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Zimmermann</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>V&#246;lkel</surname><given-names>D</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Cloning, expression, and functional characterization of the von willebrand factor-cleaving protease (ADAMTS13)</article-title>. <source>Blood</source>. <year>2002</year>;<volume>100</volume>(<issue>10</issue>):<fpage>3626</fpage>&#8211;<lpage>3632</lpage>.<pub-id pub-id-type="pmid">12393399</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2002-05-1397</pub-id></mixed-citation></ref><ref id="CIT0029"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Feys</surname><given-names>HB</given-names></string-name>, <string-name name-style="western"><surname>Canciani</surname><given-names>MT</given-names></string-name>, <string-name name-style="western"><surname>Peyvandi</surname><given-names>F</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>ADAMTS13 activity to antigen ratio in physiological and pathological conditions associated with an increased risk of thrombosis</article-title>. <source>Br J Haematol</source>. <year>2007</year>;<volume>138</volume>(<issue>4</issue>):<fpage>534</fpage>&#8211;<lpage>540</lpage>.<pub-id pub-id-type="pmid">17608762</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1365-2141.2007.06688.x</pub-id></mixed-citation></ref><ref id="CIT0030"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Xiao</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Feng</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Expression of ADAMTS13 in normal and abnormal placentae and its potential role in angiogenesis and placenta development</article-title>. <source>Arterioscler Thromb Vasc Biol</source>. <year>2017</year>;<volume>37</volume>(<issue>9</issue>):<fpage>1748</fpage>&#8211;<lpage>1756</lpage>.<pub-id pub-id-type="pmid">28751574</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1161/ATVBAHA.117.309735</pub-id><pub-id pub-id-type="pmcid">PMC5570641</pub-id></mixed-citation></ref><ref id="CIT0031"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Aref</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Goda</surname><given-names>H.</given-names></string-name></person-group><article-title>Increased VWF antigen levels and decreased ADAMTS13 activity in preeclampsia</article-title>. <source>Hematology</source>. <year>2013</year>;<volume>18</volume>(<issue>4</issue>):<fpage>237</fpage>&#8211;<lpage>241</lpage>.<pub-id pub-id-type="pmid">23433535</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1179/1607845412Y.0000000070</pub-id></mixed-citation></ref><ref id="CIT0032"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Di Mascio</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Khalil</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Saccone</surname><given-names>G</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis</article-title>. <source>Am J Obstet Gynecol MFM</source>. <year>2020</year>;<volume>2</volume>(<issue>2</issue>):<fpage>100107</fpage>.<pub-id pub-id-type="pmid">32292902</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajogmf.2020.100107</pub-id><pub-id pub-id-type="pmcid">PMC7104131</pub-id></mixed-citation></ref><ref id="CIT0033"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mendoza</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Garcia-Ruiz</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Maiz</surname><given-names>N</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Pre-eclampsia-like syndrome induced by severe COVID-19: a prospective observational study</article-title>. <source>BJOG</source>. <year>2020</year>;<volume>127</volume>(<issue>11</issue>):<fpage>1374</fpage>&#8211;<lpage>1380</lpage>.<pub-id pub-id-type="pmid">32479682</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/1471-0528.16339</pub-id><pub-id pub-id-type="pmcid">PMC7300912</pub-id></mixed-citation></ref><ref id="CIT0034"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bloise</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Nakpu</surname><given-names>J</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm birth or preeclampsia</article-title>. <source>Am J Obstet Gynecol</source>. <year>2021</year>;<volume>224</volume>(<issue>3</issue>):<fpage>298.e1-298</fpage>&#8211;<lpage>e8</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2020.08.055</pub-id><pub-id pub-id-type="pmcid">PMC7445125</pub-id><pub-id pub-id-type="pmid">32853537</pub-id></mixed-citation></ref><ref id="CIT0035"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wong</surname><given-names>SF</given-names></string-name>, <string-name name-style="western"><surname>Chow</surname><given-names>KM</given-names></string-name>, <string-name name-style="western"><surname>Leung</surname><given-names>TN</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Pregnancy and perinatal outcomes of women with severe acute respiratory syndrome</article-title>. <source>Am J Obstet Gynecol</source>. <year>2004</year>;<volume>191</volume>(<issue>1</issue>):<fpage>292</fpage>&#8211;<lpage>297</lpage>.<pub-id pub-id-type="pmid">15295381</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2003.11.019</pub-id><pub-id pub-id-type="pmcid">PMC7137614</pub-id></mixed-citation></ref><ref id="CIT0036"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Algarroba</surname><given-names>GN</given-names></string-name>, <string-name name-style="western"><surname>Rekawek</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Vahanian</surname><given-names>SA</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Visualization of severe acute respiratory syndrome coronavirus 2 invading the human placenta using electron microscopy</article-title>. <source>Am J Obstet Gynecol</source>. <year>2020</year>;<volume>223</volume>(<issue>2</issue>):<fpage>275</fpage>&#8211;<lpage>278</lpage>.<pub-id pub-id-type="pmid">32405074</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajog.2020.05.023</pub-id><pub-id pub-id-type="pmcid">PMC7219376</pub-id></mixed-citation></ref><ref id="CIT0037"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Juttukonda</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Wachman</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Boateng</surname><given-names>J</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Decidual immune response following COVID-19 during pregnancy varies by timing of maternal SARS-CoV-2 infection</article-title>. <source>J Reprod Immunol</source>. <year>2022</year>;<volume>151</volume>:<fpage>103501</fpage>.<pub-id pub-id-type="pmid">35231754</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jri.2022.103501</pub-id><pub-id pub-id-type="pmcid">PMC8867981</pub-id></mixed-citation></ref><ref id="CIT0038"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ten&#243;rio</surname><given-names>MB</given-names></string-name>, <string-name name-style="western"><surname>Ferreira</surname><given-names>RC</given-names></string-name>, <string-name name-style="western"><surname>Moura</surname><given-names>FA</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Cross-Talk between oxidative stress and inflammation in preeclampsia</article-title>. <source>Oxid Med Cell Longev</source>. <year>2019</year>;<volume>2019</volume>:26. doi:<pub-id pub-id-type="doi">10.1155/2019/8238727</pub-id><pub-id pub-id-type="pmcid">PMC6875353</pub-id><pub-id pub-id-type="pmid">31781353</pub-id></mixed-citation></ref><ref id="CIT0039"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Seethy</surname><given-names>AA</given-names></string-name>, <string-name name-style="western"><surname>Singh</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Mukherjee</surname><given-names>I</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Potential SARS-CoV-2 interactions with proteins involved in trophoblast functions &#8211; An in-silico study</article-title>. <source>Placenta</source>. <year>2021</year>;<volume>103</volume>:<fpage>141</fpage>&#8211;<lpage>151</lpage>.<pub-id pub-id-type="pmid">33126048</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.placenta.2020.10.027</pub-id><pub-id pub-id-type="pmcid">PMC7581362</pub-id></mixed-citation></ref><ref id="CIT0040"><label>40</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Gasperowicz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Surmann-Schmitt</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Hamada</surname><given-names>Y</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>The transcriptional co-repressor TLE3 regulates development of trophoblast giant cells lining maternal blood spaces in the mouse placenta</article-title>. <source>Dev Biol</source>. <year>2013</year>;<volume>382</volume>(<issue>1</issue>):<fpage>1</fpage>&#8211;<lpage>14</lpage>.<pub-id pub-id-type="pmid">23954203</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ydbio.2013.08.005</pub-id></mixed-citation></ref><ref id="CIT0041"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shanes</surname><given-names>ED</given-names></string-name>, <string-name name-style="western"><surname>Mithal</surname><given-names>LB</given-names></string-name>, <string-name name-style="western"><surname>Otero</surname><given-names>S</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Placental pathology in COVID-19</article-title>. <source>Am J Clin Pathol</source>. <year>2020</year>;<volume>154</volume>(<issue>1</issue>):<fpage>23</fpage>&#8211;<lpage>32</lpage>.<pub-id pub-id-type="pmid">32441303</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/ajcp/aqaa089</pub-id><pub-id pub-id-type="pmcid">PMC7279066</pub-id></mixed-citation></ref><ref id="CIT0042"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Zhou</surname><given-names>YY</given-names></string-name>, <string-name name-style="western"><surname>Ravishankar</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Luo</surname><given-names>G</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Predictors of high grade and other clinically significant placental findings by indication for submission in singleton placentas From term births</article-title>. <source>Pediatr Dev Pathol</source>. <year>2020</year>;<volume>23</volume>(<issue>4</issue>):<fpage>274</fpage>&#8211;<lpage>284</lpage>.<pub-id pub-id-type="pmid">32146874</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/1093526620904801</pub-id></mixed-citation></ref><ref id="CIT0043"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Khong</surname><given-names>TY</given-names></string-name>, <string-name name-style="western"><surname>Mooney</surname><given-names>EE</given-names></string-name>, <string-name name-style="western"><surname>Ariel</surname><given-names>I</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Sampling and definitions of placental lesions amsterdam placental workshop group consensus statement</article-title>. <source>Arch Pathol Lab Med</source>. <year>2016</year>;<volume>140</volume>(<issue>7</issue>):<fpage>698</fpage>&#8211;<lpage>713</lpage>.<pub-id pub-id-type="pmid">27223167</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5858/arpa.2015-0225-CC</pub-id></mixed-citation></ref><ref id="CIT0044"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Bustamante Helfrich</surname><given-names>B</given-names></string-name>, <string-name name-style="western"><surname>Chilukuri</surname><given-names>N</given-names></string-name>, <string-name name-style="western"><surname>He</surname><given-names>H</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Maternal vascular malperfusion of the placental bed associated with hypertensive disorders in the boston birth cohort</article-title>. <source>Placenta</source>. <year>2017</year>;<volume>52</volume>:<fpage>106</fpage>&#8211;<lpage>113</lpage>.<pub-id pub-id-type="pmid">28454692</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.placenta.2017.02.016</pub-id><pub-id pub-id-type="pmcid">PMC5412713</pub-id></mixed-citation></ref><ref id="CIT0045"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Weiner</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Feldstein</surname><given-names>O</given-names></string-name>, <string-name name-style="western"><surname>Tamayev</surname><given-names>L</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Placental histopathological lesions in correlation with neonatal outcome in preeclampsia with and without severe features</article-title>. <source>Pregnancy Hypertens</source>. <year>2018</year>;<volume>12</volume>:<fpage>6</fpage>&#8211;<lpage>10</lpage>.<pub-id pub-id-type="pmid">29674201</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.preghy.2018.02.001</pub-id></mixed-citation></ref><ref id="CIT0046"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Guida</surname><given-names>JP</given-names></string-name>, <string-name name-style="western"><surname>Cecatti</surname><given-names>JG</given-names></string-name>, <string-name name-style="western"><surname>Souza</surname><given-names>RT</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Preeclampsia among women with COVID-19 during pregnancy and its impact on maternal and perinatal outcomes: results from a national multicenter study on COVID in Brazil, the REBRACO initiative</article-title>. <source>Pregnancy Hypertens</source>. <year>2022</year>;<volume>28</volume>:<fpage>168</fpage>&#8211;<lpage>173</lpage>.<pub-id pub-id-type="pmid">35568019</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.preghy.2022.05.005</pub-id><pub-id pub-id-type="pmcid">PMC9085347</pub-id></mixed-citation></ref><ref id="CIT0047"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tran</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Alessandrini</surname><given-names>V</given-names></string-name>, <string-name name-style="western"><surname>Lepercq</surname><given-names>J</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Risk of preeclampsia in patients with symptomatic COVID-19 infection</article-title>. <source>J Gynecol Obstet Hum Reprod</source>. <year>2022</year>;<volume>51</volume>(<issue>9</issue>):<fpage>102459</fpage>.<pub-id pub-id-type="pmid">35981706</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jogoh.2022.102459</pub-id><pub-id pub-id-type="pmcid">PMC9376977</pub-id></mixed-citation></ref><ref id="CIT0048"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Marchand</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Patil</surname><given-names>AS</given-names></string-name>, <string-name name-style="western"><surname>Masoud</surname><given-names>AT</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Systematic review and meta-analysis of COVID-19 maternal and neonatal clinical features and pregnancy outcomes up to June 3, 2021</article-title>. <source>AJOG Glob Reports</source>. <year>2022</year>;<volume>2</volume>(<issue>1</issue>):<fpage>100049</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.xagr.2021.100049</pub-id><pub-id pub-id-type="pmcid">PMC8720679</pub-id><pub-id pub-id-type="pmid">35005663</pub-id></mixed-citation></ref><ref id="CIT0049"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cardona-P&#233;rez</surname><given-names>JA</given-names></string-name>, <string-name name-style="western"><surname>Villegas-Mota</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Helguera-Repetto</surname><given-names>AC</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Prevalence, clinical features, and outcomes of SARS-CoV-2 infection in pregnant women with or without mild/moderate symptoms: results from universal screening in a tertiary care center in Mexico city, Mexico</article-title>. <source>PLoS One</source>. <year>2021</year>;<volume>16</volume>(<issue>4</issue>):<fpage>e0249584</fpage>.<pub-id pub-id-type="pmid">33886590</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1371/journal.pone.0249584</pub-id><pub-id pub-id-type="pmcid">PMC8062012</pub-id></mixed-citation></ref><ref id="CIT0050"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Villar</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Ariff</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Gunier</surname><given-names>RB</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Maternal and neonatal morbidity and mortality Among pregnant women With and Without COVID-19 infection: the INTERCOVID multinational cohort study</article-title>. <source>JAMA Pediatr</source>. <year>2021</year>;<volume>175</volume>(<issue>8</issue>):<fpage>817</fpage>&#8211;<lpage>826</lpage>.<pub-id pub-id-type="pmid">33885740</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamapediatrics.2021.1050</pub-id><pub-id pub-id-type="pmcid">PMC8063132</pub-id></mixed-citation></ref><ref id="CIT0051"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tossetta</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Fantone</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Delli Muti</surname><given-names>N</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Preeclampsia and severe acute respiratory syndrome coronavirus 2 infection: a systematic review</article-title>. <source>J Hypertens</source>. <year>2022</year>;<volume>40</volume>(<issue>9</issue>):<fpage>1629</fpage>&#8211;<lpage>1638</lpage>.<pub-id pub-id-type="pmid">35943095</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/HJH.0000000000003213</pub-id><pub-id pub-id-type="pmcid">PMC10860893</pub-id></mixed-citation></ref><ref id="CIT0052"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Taglauer</surname><given-names>ES</given-names></string-name>, <string-name name-style="western"><surname>Wachman</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Juttukonda</surname><given-names>L</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Acute severe acute respiratory syndrome coronavirus 2 infection in pregnancy Is associated with placental Angiotensin-Converting enzyme 2 shedding</article-title>. <source>Am J Pathol</source>. <year>2022</year>;<volume>192</volume>(<issue>4</issue>):<fpage>595</fpage>&#8211;<lpage>603</lpage>.<pub-id pub-id-type="pmid">35090860</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ajpath.2021.12.011</pub-id><pub-id pub-id-type="pmcid">PMC8789383</pub-id></mixed-citation></ref><ref id="CIT0053"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Celewicz</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Celewicz</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Michalczyk</surname><given-names>M</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Pregnancy as a risk factor of severe COVID-19</article-title>. <source>J Clin Med</source>. <year>2021</year>;<volume>10</volume>(<issue>22</issue>):<fpage>10</fpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/jcm10225458</pub-id><pub-id pub-id-type="pmcid">PMC8625663</pub-id><pub-id pub-id-type="pmid">34830740</pub-id></mixed-citation></ref><ref id="CIT0054"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Jia</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Neptune</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Cui</surname><given-names>H.</given-names></string-name></person-group><article-title>Targeting ACE2 for COVID-19 therapy: opportunities and challenges</article-title>. <source>Am J Respir Cell Mol Biol</source>. <year>2021</year>;<volume>64</volume>(<issue>4</issue>):<fpage>416</fpage>&#8211;<lpage>425</lpage>.<pub-id pub-id-type="pmid">33296619</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1165/rcmb.2020-0322PS</pub-id><pub-id pub-id-type="pmcid">PMC8008810</pub-id></mixed-citation></ref><ref id="CIT0055"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mor</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Aldo</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Alvero</surname><given-names>AB.</given-names></string-name></person-group><article-title>The unique immunological and microbial aspects of pregnancy</article-title>. <source>Nat Rev Immunol</source>. <year>2017</year>;<volume>17</volume>(<issue>8</issue>):<fpage>469</fpage>&#8211;<lpage>482</lpage>.<pub-id pub-id-type="pmid">28627518</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri.2017.64</pub-id></mixed-citation></ref><ref id="CIT0056"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Racicot</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Mor</surname><given-names>G.</given-names></string-name></person-group><article-title>Risks associated with viral infections during pregnancy</article-title>. <source>J Clin Invest</source>. <year>2017</year>;<volume>127</volume>(<issue>5</issue>):<fpage>1591</fpage>&#8211;<lpage>1599</lpage>.<pub-id pub-id-type="pmid">28459427</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI87490</pub-id><pub-id pub-id-type="pmcid">PMC5409792</pub-id></mixed-citation></ref><ref id="CIT0057"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Barcelos</surname><given-names>IDES</given-names></string-name>, <string-name name-style="western"><surname>Penna Ia de</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Soligo A de</surname><given-names>G</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Vertical transmission of SARS-CoV-2: a systematic review</article-title>. <source>Rev Bras Ginecol Obstet</source>. <year>2021</year>;<volume>43</volume>(<issue>3</issue>):<fpage>207</fpage>&#8211;<lpage>215</lpage>.<pub-id pub-id-type="pmid">33860504</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0040-1722256</pub-id><pub-id pub-id-type="pmcid">PMC10183886</pub-id></mixed-citation></ref><ref id="CIT0058"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tay</surname><given-names>MZ</given-names></string-name>, <string-name name-style="western"><surname>Poh</surname><given-names>CM</given-names></string-name>, <string-name name-style="western"><surname>R&#233;nia</surname><given-names>L</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>The Trinity of COVID-19: immunity, inflammation and intervention</article-title>. <source>Nat Rev Immunol</source>. <year>2020</year>;<volume>20</volume>(<issue>6</issue>):<fpage>363</fpage>&#8211;<lpage>374</lpage>.<pub-id pub-id-type="pmid">32346093</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41577-020-0311-8</pub-id><pub-id pub-id-type="pmcid">PMC7187672</pub-id></mixed-citation></ref><ref id="CIT0059"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Huang</surname><given-names>C</given-names></string-name>, <string-name name-style="western"><surname>Wang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Li</surname><given-names>X</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China</article-title>. <source>Lancet</source>. <year>2020</year>;<volume>395</volume>(<issue>10223</issue>):<fpage>497</fpage>&#8211;<lpage>506</lpage>.<pub-id pub-id-type="pmid">31986264</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(20)30183-5</pub-id><pub-id pub-id-type="pmcid">PMC7159299</pub-id></mixed-citation></ref><ref id="CIT0060"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ghi</surname><given-names>T</given-names></string-name>, <string-name name-style="western"><surname>di Pasquo</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Mekinian</surname><given-names>A</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Sars-CoV-2 in pregnancy: why is it better than expected?</article-title><source>Eur J Obstet Gynecol Reprod Biol</source>. <year>2020</year>;<volume>252</volume>:<fpage>476</fpage>&#8211;<lpage>478</lpage>.<pub-id pub-id-type="pmid">32739606</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejogrb.2020.07.025</pub-id><pub-id pub-id-type="pmcid">PMC7378463</pub-id></mixed-citation></ref><ref id="CIT0061"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Juttukonda</surname><given-names>LJ</given-names></string-name>, <string-name name-style="western"><surname>Wachman</surname><given-names>EM</given-names></string-name>, <string-name name-style="western"><surname>Boateng</surname><given-names>J</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>The impact of maternal SARS-CoV-2 vaccination and first trimester infection on feto-maternal immune responses</article-title>. <source>Am J Reprod Immunol</source>. <year>2022</year>;<volume>88</volume>(<issue>6</issue>):<fpage>e13625</fpage>.<pub-id pub-id-type="pmid">36123778</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/aji.13625</pub-id><pub-id pub-id-type="pmcid">PMC9538740</pub-id></mixed-citation></ref><ref id="CIT0062"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Racicot</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>Kwon</surname><given-names>JY</given-names></string-name>, <string-name name-style="western"><surname>Aldo</surname><given-names>P</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Type I interferon regulates the placental inflammatory response to bacteria and is targeted by virus: mechanism of polymicrobial Infection-Induced preterm birth</article-title>. <source>Am J Reprod Immunol</source>. <year>2016</year>;<volume>75</volume>(<issue>4</issue>):<fpage>451</fpage>&#8211;<lpage>460</lpage>.<pub-id pub-id-type="pmid">26892235</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/aji.12501</pub-id><pub-id pub-id-type="pmcid">PMC5599852</pub-id></mixed-citation></ref><ref id="CIT0063"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Abrahams</surname><given-names>VM</given-names></string-name>, <string-name name-style="western"><surname>Mor</surname><given-names>G.</given-names></string-name></person-group><article-title>Toll-like receptors and their role in the trophoblast</article-title>. <source>Placenta</source>. <year>2005</year>;<volume>26</volume>(<issue>7</issue>):<fpage>540</fpage>&#8211;<lpage>547</lpage>.<pub-id pub-id-type="pmid">15993703</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.placenta.2004.08.010</pub-id></mixed-citation></ref><ref id="CIT0064"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Ivashkiv</surname><given-names>LB</given-names></string-name>, <string-name name-style="western"><surname>Donlin</surname><given-names>LT.</given-names></string-name></person-group><article-title>Regulation of type i interferon responses</article-title>. <source>Nat Rev Immunol</source>. <year>2014</year>;<volume>14</volume>(<issue>1</issue>):<fpage>36</fpage>&#8211;<lpage>49</lpage>.<pub-id pub-id-type="pmid">24362405</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nri3581</pub-id><pub-id pub-id-type="pmcid">PMC4084561</pub-id></mixed-citation></ref><ref id="CIT0065"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Aboagye-Mathiesen</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>T&#243;th</surname><given-names>FD</given-names></string-name>, <string-name name-style="western"><surname>Zdravkovic</surname><given-names>M</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Functional characteristics of human trophoblast interferons</article-title>. <source>Am J Reprod Immunol</source>. <year>1996</year>;<volume>35</volume>(<issue>4</issue>):<fpage>309</fpage>&#8211;<lpage>317</lpage>.<pub-id pub-id-type="pmid">8739446</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0897.1996.tb00486.x</pub-id></mixed-citation></ref><ref id="CIT0066"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Lee</surname><given-names>BN</given-names></string-name>, <string-name name-style="western"><surname>Hammill</surname><given-names>H</given-names></string-name>, <string-name name-style="western"><surname>Popek</surname><given-names>EJ</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Production of interferons and &#946;-chemokines by placental trophoblasts of HIV-1-infected women</article-title>. <source>Infect Dis Obstet Gynecol</source>. <year>2001</year>;<volume>9</volume>(<issue>2</issue>):<fpage>95</fpage>&#8211;<lpage>104</lpage>.<pub-id pub-id-type="pmid">11495560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/S1064744901000175</pub-id><pub-id pub-id-type="pmcid">PMC1784647</pub-id></mixed-citation></ref><ref id="CIT0067"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Odorizzi</surname><given-names>PM</given-names></string-name>, <string-name name-style="western"><surname>Wherry</surname><given-names>EJ.</given-names></string-name></person-group><article-title>An interferon paradox</article-title>. <source>Science</source>. <year>2013</year>;<volume>340</volume>(<issue>6129</issue>):<fpage>155</fpage>&#8211;<lpage>156</lpage>.<pub-id pub-id-type="pmid">23580520</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1237568</pub-id><pub-id pub-id-type="pmcid">PMC4886223</pub-id></mixed-citation></ref><ref id="CIT0068"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Sharif</surname><given-names>MN</given-names></string-name>, <string-name name-style="western"><surname>&#352;o&#353;i&#263;</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Rothlin</surname><given-names>CV</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Twist mediates suppression of inflammation by type I IFNs and axl</article-title>. <source>J Exp Med</source>. <year>2006</year>;<volume>203</volume>(<issue>8</issue>):<fpage>1891</fpage>&#8211;<lpage>1901</lpage>. doi:<pub-id pub-id-type="doi">10.1084/jem.20051725</pub-id><pub-id pub-id-type="pmid">16831897</pub-id><pub-id pub-id-type="pmcid">PMC2118370</pub-id></mixed-citation></ref><ref id="CIT0069"><label>69</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Tian</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></string-name>, <string-name name-style="western"><surname>Liu</surname><given-names>Z</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>The PD-1/PD-L1 inhibitory pathway is altered in pre-eclampsia and regulates T cell responses in pre-eclamptic rats</article-title>. <source>Sci Rep</source>. <year>2016</year>;<volume>6</volume>:<fpage>27683</fpage> doi:<pub-id pub-id-type="doi">10.1038/srep27683</pub-id><pub-id pub-id-type="pmid">27277012</pub-id><pub-id pub-id-type="pmcid">PMC4899740</pub-id></mixed-citation></ref><ref id="CIT0070"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Boasso</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Hardy</surname><given-names>AW</given-names></string-name>, <string-name name-style="western"><surname>Anderson</surname><given-names>SA</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation</article-title>. <source>PLoS One</source>. <year>2008</year>;<volume>3</volume>(<issue>8</issue>):<fpage>e2961</fpage> doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0002961</pub-id><pub-id pub-id-type="pmid">18698365</pub-id><pub-id pub-id-type="pmcid">PMC2491901</pub-id></mixed-citation></ref><ref id="CIT0071"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Wilson</surname><given-names>EB</given-names></string-name>, <string-name name-style="western"><surname>Brooks</surname><given-names>DG.</given-names></string-name></person-group><article-title>Decoding the complexity of type I interferon to treat persistent viral infections</article-title>. <source>Trends Microbiol</source>. <year>2013</year>;<volume>21</volume>(<issue>12</issue>):<fpage>634</fpage>&#8211;<lpage>640</lpage>.<pub-id pub-id-type="pmid">24216022</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.tim.2013.10.003</pub-id><pub-id pub-id-type="pmcid">PMC3864553</pub-id></mixed-citation></ref><ref id="CIT0072"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Garc&#237;a-Sastre</surname><given-names>A</given-names></string-name>, <string-name name-style="western"><surname>Biron</surname><given-names>CA.</given-names></string-name></person-group><article-title>Type 1 interferons and the virus-host relationship: a lesson in d&#233;tente</article-title>. <source>Science</source>. <year>2006</year>;<volume>312</volume>(<issue>5775</issue>):<fpage>879</fpage>&#8211;<lpage>882</lpage>.<pub-id pub-id-type="pmid">16690858</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/science.1125676</pub-id></mixed-citation></ref><ref id="CIT0073"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cappelletti</surname><given-names>M</given-names></string-name>, <string-name name-style="western"><surname>Della Bella</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Ferrazzi</surname><given-names>E</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Inflammation and preterm birth</article-title>. <source>J Leukoc Biol</source>. <year>2016</year>;<volume>99</volume>(<issue>1</issue>):<fpage>67</fpage>&#8211;<lpage>78</lpage>.<pub-id pub-id-type="pmid">26538528</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1189/jlb.3MR0615-272RR</pub-id></mixed-citation></ref><ref id="CIT0074"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cardenas</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Means</surname><given-names>RE</given-names></string-name>, <string-name name-style="western"><surname>Aldo</surname><given-names>P</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Viral infection of the placenta leads to fetal inflammation and sensitization to bacterial products predisposing to preterm labor</article-title>. <source>J Immunol</source>. <year>2010</year>;<volume>185</volume>(<issue>2</issue>):<fpage>1248</fpage>&#8211;<lpage>1257</lpage>.<pub-id pub-id-type="pmid">20554966</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4049/jimmunol.1000289</pub-id><pub-id pub-id-type="pmcid">PMC3041595</pub-id></mixed-citation></ref><ref id="CIT0075"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Romero</surname><given-names>R</given-names></string-name>, <string-name name-style="western"><surname>Chaemsaithong</surname><given-names>P</given-names></string-name>, <string-name name-style="western"><surname>Chaiyasit</surname><given-names>N</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>CXCL10 and IL-6: markers of two different forms of intra-amniotic inflammation in preterm labor</article-title>. <source>Am J Reprod Immunol</source>. <year>2017</year>;<volume>78</volume>(<issue>1</issue>):<fpage>e12685</fpage>.<pub-id pub-id-type="pmid">28544362</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/aji.12685</pub-id><pub-id pub-id-type="pmcid">PMC5488235</pub-id></mixed-citation></ref><ref id="CIT0076"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Cardenas</surname><given-names>I</given-names></string-name>, <string-name name-style="western"><surname>Mor</surname><given-names>G</given-names></string-name>, <string-name name-style="western"><surname>Aldo</surname><given-names>P</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Placental viral infection sensitizes to Endotoxin-Induced Pre-Term labor: a double hit hypothesis</article-title>. <source>Am J Reprod Immunol</source>. <year>2011</year>;<volume>65</volume>(<issue>2</issue>):<fpage>110</fpage>&#8211;<lpage>117</lpage>.<pub-id pub-id-type="pmid">20712808</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/j.1600-0897.2010.00908.x</pub-id><pub-id pub-id-type="pmcid">PMC3025809</pub-id></mixed-citation></ref><ref id="CIT0077"><label>77</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>McGonagle</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Sharif</surname><given-names>K</given-names></string-name>, <string-name name-style="western"><surname>O&#8217;Regan</surname><given-names>A</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation Syndrome-Like disease</article-title>. <source>Autoimmun Rev</source>. <year>2020</year>;<volume>19</volume>(<issue>6</issue>):<fpage>102537</fpage>.<pub-id pub-id-type="pmid">32251717</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.autrev.2020.102537</pub-id><pub-id pub-id-type="pmcid">PMC7195002</pub-id></mixed-citation></ref><ref id="CIT0078"><label>78</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Shevyrev</surname><given-names>D</given-names></string-name>, <string-name name-style="western"><surname>Tereshchenko</surname><given-names>V.</given-names></string-name></person-group><article-title>Treg heterogeneity, function, and homeostasis</article-title>. <source>Front Immunol</source>. <year>2020</year>;<volume>10</volume>:<fpage>3100</fpage> doi:<pub-id pub-id-type="doi">10.3389/fimmu.2019.03100</pub-id><pub-id pub-id-type="pmid">31993063</pub-id><pub-id pub-id-type="pmcid">PMC6971100</pub-id></mixed-citation></ref><ref id="CIT0079"><label>79</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Mark</surname><given-names>EG</given-names></string-name>, <string-name name-style="western"><surname>McAleese</surname><given-names>S</given-names></string-name>, <string-name name-style="western"><surname>Golden</surname><given-names>WC</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Coronavirus disease 2019 in pregnancy and outcomes among pregnant women and neonates: a literature review</article-title>. <source>Pediatr Infect Dis J</source>. <year>2021</year>;<volume>40</volume>(<issue>5</issue>):<fpage>473</fpage>&#8211;<lpage>478</lpage>.<pub-id pub-id-type="pmid">33847297</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/INF.0000000000003102</pub-id><pub-id pub-id-type="pmcid">PMC8048372</pub-id></mixed-citation></ref><ref id="CIT0080"><label>80</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Adhikari</surname><given-names>EH</given-names></string-name>, <string-name name-style="western"><surname>Moreno</surname><given-names>W</given-names></string-name>, <string-name name-style="western"><surname>Zofkie</surname><given-names>AC</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Pregnancy outcomes Among women With and Without severe acute respiratory syndrome coronavirus 2 infection</article-title>. <source>JAMA Netw Open</source>. <year>2020</year>;<volume>3</volume>(<issue>11</issue>):<fpage>e2029256</fpage>.<pub-id pub-id-type="pmid">33211113</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1001/jamanetworkopen.2020.29256</pub-id><pub-id pub-id-type="pmcid">PMC7677755</pub-id></mixed-citation></ref><ref id="CIT0081"><label>81</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name name-style="western"><surname>Allotey</surname><given-names>J</given-names></string-name>, <string-name name-style="western"><surname>Stallings</surname><given-names>E</given-names></string-name>, <string-name name-style="western"><surname>Bonet</surname><given-names>M</given-names></string-name>, <etal>et&#160;al.</etal></person-group><article-title>Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis</article-title>. <source>BMJ</source>. <year>2020</year>;<volume>370</volume>(<issue>1</issue>):<fpage>1641</fpage>&#8211;<lpage>1647</lpage>.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.m3320</pub-id><pub-id pub-id-type="pmcid">PMC7459193</pub-id><pub-id pub-id-type="pmid">32873575</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>